Immunological Aspects of Depressive Disorder - The Review

1 Mihajlović, G., Janković, S., Timotijević, I., Đukić Dejanović, S. Depresije i individualizacija doziranja antidepresiva. Kragujevac: Medicinski fakultet u Kragujevcu; 2001. Search in Google Scholar

2 Paunović, V. O depresijama. Acta clinica. Beograd: Klinički Centar Srbije; 2005. Search in Google Scholar

3 Ministarstvo zdravlja Republike Srbije. Nacionalni vodič dobre kliničke prakse za dijagnostikovanje i lečenje depresije. Beograd: Agencija za akreditaciju zdravstvenih ustanova Srbije; 2011. Search in Google Scholar

4 Alvarez E, Perez V, Artigas F. Pharmacology and clinical potential od vortioxetine in the treatment of major depressive disorder. Neuropsychiatr Dis Treat. 2014;10:1297-307. Search in Google Scholar

5 Elomaa AP, Niskanen L, Herzig KH, Viinamäki H, Hintikka J, Koivumaa-Honkanen H, et al. Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder. BMC Psychiatry 2012;12:2. Search in Google Scholar

6 Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:201–17. Search in Google Scholar

7 Dantzer R, Bluthe RM, Ghensi G, Cremona S, Laye S, Parnet P, et al. Ann. N Y Acad. Sci. 1998;856, 132-8. Search in Google Scholar

8 Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46–56. Search in Google Scholar

9 Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J,et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141:599-609. Search in Google Scholar

10 Liang S, Wang T, Hu X, Luo J, Li W, Wu X, et al. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience. 2015;310:561-77. Search in Google Scholar

11 Hayley S, Audet MC, Anisman H. Inflammation and the microbiome: implications for depressive disorders.Curr Opin Pharmcol. 2016;29:42-6. Search in Google Scholar

12 Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationship of depression and stressors to immunological assays: a metanalytic review. Brain Behav Immun 2001;15:199–226. Search in Google Scholar

13 Leboyer M, Berk M, Yolken RH, Tamouza R, Kupfer D, Groc L. Immuno-psychiatry: an agenda for clinical practice and innovative research. BMC Medicine 2016;14(1):173. Search in Google Scholar

14 Pariante CM. Psychoneuroimmunology or immunopsychiatry? Lancet Psychiatry. 2015;2(3):197-9. Search in Google Scholar

15 Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain, Behavior, and Immunity. 2011;25:221–9. Search in Google Scholar

16 Raison CL, Capuron, L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27: 24–31. Search in Google Scholar

17 Kohler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 2014; 71:1381–91. Search in Google Scholar

18 Benros ME, Waltoft BL, Nordentoft M, Ostergaard SD, Eaton WW, Krogh J et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 2013;12:1–9. Search in Google Scholar

19 Louveau A, Harris TH, Kipnis J. Revisiting the concept of CNS immune privilege. Trends Immunol 2015;36(10):569-77. Search in Google Scholar

20 Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immun. 2007;21:727–35. Search in Google Scholar

21 Bhalla RK, Butters MA, Mulsant BH, Begley AE, Zmuda MD, Schoderbek B, et al. Persistence of neuro-psychologic deficits in the remitted state of late-life depression. Am. J. Geriatr. Psychiatry. 2006;14:419-27. Search in Google Scholar

22 Misiak B, Beszłej JA, Kotowicz K, SzewczukBogusławska M, Samochowiec J, Kucharska-Mazur J. et al. Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets. Prog Neuropsychopharmacol Biol Psychiatry. 2018; 80:177-188. Search in Google Scholar

23 Ridout KK, Parade SH, Seifer R et al. Interleukin 1B gene (IL1B) variation and internalizing symptoms in maltreated preschoolers. Dey Psychopathol. 2014;26:1277-87. Search in Google Scholar

24 Ellul P, Boyer L, Groc L, Leboyer M, Fond G. Interleukin-1 b-targeted treatment strategies in inflammatory depression: toward personalized care. Acta Psychiatr Scand. 2016; 134(6):469-84. Search in Google Scholar

25 Euteneuer F, Dannehl K, Del Rey A, Engler H, Schedlowski M, Rief W. Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial. Transl Psychiatry 2017;7:e1132. Search in Google Scholar

26 Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. Lancet 2006;367:29 – 35. Search in Google Scholar

27 Goldsmith DR, Rapaport MH, Miller BJ. A metaanalysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696-1709. Search in Google Scholar

28 Kuo FC, Lee CH, Hsieh CH, Kuo P, Chen YC, Hung YJ. Lifestyle modification and behavior therapy effectively reduce body weight and increase serum level of brain-derived neurotrophic factor in obsess nondiabetic patients with schizophrenia. Psychiatry Res 2013;209:150–4. Search in Google Scholar

29 Ohgi Y, Futamura T, Kikuchi T, Hashimoto K. Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacol. Biochem. Behav. 2013;103: 856–9. Search in Google Scholar

30 Borland LM, Michael AC. Voltammetric study of the control of striatal dopamine release by glutamate. JNeurochem 2004;91:220-9. Search in Google Scholar

31 Tilleux S, Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders.J Neurosci Res 2007;85:2059–70. Search in Google Scholar

32 Laugeray A, Launay JM, Callebert J, Mutlu O, Guillemin GJ, Barone PR. Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice Comparison with Fluoxetine. PLOS one. 2016;11(11):e0164337. Search in Google Scholar

33 Zhang JC, Yao W, Hashimoto K. Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets. Current Neuropharmacology 2016;14(7): 721-31. Search in Google Scholar

34 Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosisfactor-alpha activate serotonin transporters. Neuropsycho-pharmacology 2006; 31:2121–31. Search in Google Scholar

35 Kitagami T, Yamada K, Miura H, Hashimoto R, Nabeshima T, Ohta T. Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: Role of nitric oxide as a signal crossing the blood- brain barrier. Brain Res 2003;978:104–14. Search in Google Scholar

36 Won E, Kim YK. Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression. Current Neuropharmacology 2016;14(7):665-73. Search in Google Scholar

37 McEwen BS, Eiland L, Hunter RG, Miller MM. Stress and anxiety:structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 2012;62:3–12. Search in Google Scholar

38 Zhou L, Xiong J, Lim Y, et al. Upregulation of blood proBDNF and its receptors in major depression. J Affect Disord. 2013;150(3):776–84. Search in Google Scholar

39 Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104–10. Search in Google Scholar

40 Ascoli BM, Géa LP, Colombo R, Barbé-Tuana FM, Kapczinski F, Rosa AR. The role of macrophage polarization on bipolar disorder: identifying new therapeutic targets. Aust. N Z J. Psychiatry 2016;50:618–30. Search in Google Scholar

41 Biber K, Möller T, Bodekke E, Prinz M. Central nervous system myeloid cells as drug targets: current status and translational challenges. Nat. Rev. Drug Discov. 2016;15:110–24. Search in Google Scholar

42 Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. The inflammatory & neurodenegerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009;24:27-53. Search in Google Scholar

43 Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain, Behavior and Immunity 2007;21(1): 9-19. Search in Google Scholar

44 Pariante CM, Pearce BD, Pisell TL, Owens MJ, Miller AH. Steroid independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol Pharmacol 1997;52:571-81. Search in Google Scholar

45 Carvalho LA, Bergink V, Sumaski L, Wijkhuijs J, Hoogendijk WJ, Birkenhager TK et al. Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Translational Psychiatry 2014;4:e344. Search in Google Scholar

46 Miyaoka H, Otsubo T, Kamijima K, Ishii M, Onuki M, Mitamura K. Depression from interferon therapy in patients with hepatitis C. Am.J. Psychiatry 1999;156:1120. Search in Google Scholar

47 Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71. Search in Google Scholar

48 Capuron L, Ravaud A, Dantzer R. Timing and specificity of the cognitive changes induced by interleukin-2and interferon-alpha treatments in cancer patients. Psychosom Med. 2001; 63:376–86. Search in Google Scholar

49 Bull SJ, Huezo-Diaz P, Binder EB, Cubells JF, Ranjith G, Maddock C. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry 2009;14:1095-1104. Search in Google Scholar

50 Irwin, M. Immune correlates of depression. Adv. Exp. Med. Biol. 1999;461:1-24. Search in Google Scholar

51 Mavoungou E, Bouyou-Akotet MK, Kremsner PG. Interaction Between Natural Killer Cells, Cortisol and Prolactin in Malaria During Pregnancy. Clin. Exp. Immunol. 2005;139:287-96. Search in Google Scholar

52 Sanders VM, Straub RH. Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav. Immun. 2002;16:290–332. Search in Google Scholar

53 Nieman DC, Nehlsen-Cannarella SL, Markoff PA, Balk-Lamberton AJ, Yang H, Chritton, DBW, et al. Theeffects of moderate exercise training on natural killer cells and acute upper respiratory tract infections. Int. J. Sports Med. 1990;467–73; Search in Google Scholar

54 Herbert TB, Cohen S. Depression and immunity—a metanalytic review. Psychol. Bull. 1993; 113:472–86. Search in Google Scholar

55 Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain Behav. Immun. 2011;25:221–9. Search in Google Scholar

56 Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A 2003;100:9090–5. Search in Google Scholar

57 Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactiveprotein, IL-1and IL-6: a metaanalysis. Psychosom.Med. 2009;71:171–86. Search in Google Scholar

58 Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010; 67: 446–57. Search in Google Scholar

59 Guo J, Liu C, Wang Y, et al. Role of T helper lymphokines in the immune-inflammatory pathophysiology of schizophrenia: systematic review and meta-analysis. Nord J Psychiatry. 2015;69:364–72. Search in Google Scholar

60 Borovcanin M, Jovanovic I, Radosavljevic G, et al. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. J Psychiatr Res. 2012;46:1421–26. Search in Google Scholar

61 Li Y, Xiao B, Qiu W, Yang L, Hu B, Tian X et al. Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder. J. Affect. Disord. 2010;124:68–75. Search in Google Scholar

62 Bartrop RW, Luckhurst E, Lazarus L, Kiloh LG, Penny R. Depressed lymphocyte function after bereavement. Lancet 1977;1:834–36. Search in Google Scholar

63 Eilat E, Mendlovic S, Doron A, Zakuth V, Spirer Z. Increased apoptosis in patients with major depression: a preliminary study. J. Immunol. 1999; 163: 533–34. Search in Google Scholar

64 Baniyash M. Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin Cancer Biol 2006;16:80–8. Search in Google Scholar

65 Wong M, Dong C, Maestre-Mesa J, Licinio J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol. Psychiatry 2008;13:800–12. Search in Google Scholar

66 Davami MH, Baharlou R, Ahmadi Vasmehjani A, Ghanizadeh A, Keshtkar M, Dezhkam I, et al. Elevated IL17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-InflammatoryResponses with Major Depressive Disorder. Basic and Clinical Neuroscience 2016;7(2):137-142. Search in Google Scholar

67 Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom. Med. 2008;70:539–45. Search in Google Scholar

68 Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner ER, et al. Neopterin: biochemistry,methods, and clinical application. Berlin–New York: Walter de Gruyter; 1992. Search in Google Scholar

69 Lewitus GM, Wilf-Yarkoni A, Ziv Y. Vaccination as a novel approach for treating depressive behavior. Biol. Psychiatry 2009;65:283–8. Search in Google Scholar